MedTrace Logo

Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

NCT06397677 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2024-05-03

No results posted yet for this study

Summary

A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression.

The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progression. The investigators will do this using a combination of clinical, radiologic, and biologic features.

Conditions

Interventions

GENETIC

Research Testing Performed (Laboratory)

Blood collection (DNA, RNA)

DIAGNOSTIC_TEST

Information Collected as Standard of Care

High Resolution CT Scan (Chest), Pulmonary Function Testing (PFT), 6-Minute Walk Test (6MWT)

OTHER

Research Testing Performed

Blood collection (non-genetic), Buccal Swab, Rheumatologic Assessment, Pulmonary Assessment, Questionnaires

Sponsors & Collaborators

Principal Investigators

  • Joyce S Lee · University of Colorado, Denver

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-22
Primary Completion
2029-01-31
Completion
2034-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06397677 on ClinicalTrials.gov